biodefense


Also found in: Dictionary, Thesaurus, Acronyms, Wikipedia.

biodefense

(bī″ō-dĕ-fĕns′) [″ + ″]
National or international efforts to prevent the spread of biologically destructive agents, esp. when they are used in terrorism or warfare.
Mentioned in ?
References in periodicals archive ?
77 billion for civilian biodefense for the Departments of Homeland Security and Health and Human Services, in addition to funds for biodefense provided under Project Bioshield.
As a consequence, the international community understandably has less and less confidence that the US biodefense program is peaceable.
As identified by the recently convened NIAID Blue Ribbon Panel on Bioterrorism and Its Implications for Biomedical Research, there is a critical need for the establishment of highly developed research and development infrastructure with strong translational research capacity to implement the Biodefense Research Agenda of the NIAID (for more information, visit http://www.
Among the products in its biodefense product portfolio, Emergent BioSolutions manufactures and sells BioThrax[R] (Anthrax Vaccine Adsorbed), the only vaccine licensed by the FDA for the prevention of anthrax, and is developing an anthrax immune globulin, a botulinum vaccine and a botulinum immune globulin.
The Company operates in two business segments: biodefense and commercial.
In addition to this contract for anti-infective therapeutic development, SRI has worked for many years with NIAID's Division of AIDS conducting safety, formulation, and clinical manufacturing projects, as well as with the NIAID biodefense safety, vaccine, and screening programs.
Bob brings an exceptional breadth of experience gained in a career spanning public health and biodefense policy in both the Executive Branch and Congress.
Closing this financing round with CNF Investments and Chart Venture Partners enables the company to bolster its research and development and commercialization efforts relative to the biodefense and human clinical diagnostics markets," said Joe Hernandez, IBI's President and CEO.
With this funding and additional funding from the National Institutes of Health for the development of an RNAi therapeutic targeting the Ebola virus, we are advancing our Alnylam Biodefense efforts to meet bio-preparedness needs for U.
Through our BioDefense Division, we are developing biomedical countermeasures pursuant to the recently enacted Project BioShield Act of 2004.